T Yoshioka Selected Research

carboxymethylpullulan- phenylglycyl- doxorubicin conjugate

12/2000

Improved in vivo antitumor efficacy and reduced systemic toxicity of carboxymethylpullulan-peptide-doxorubicin conjugates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

T Yoshioka Research Topics

Disease

16	Neoplasms (Cancer) 09/2015 - 01/2000
4	Neoplasm Metastasis (Metastasis) 05/2001 - 01/2000
3	Dermatitis 01/2009 - 04/2003
3	Body Weight (Weight, Body) 10/2001 - 01/2000
3	Lung Neoplasms (Lung Cancer) 01/2001 - 01/2000
2	Atrophy 01/2017 - 02/2000
2	Infections 01/2015 - 02/2000
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2015 - 12/2000
2	Atopic Dermatitis (Atopic Eczema) 10/2012 - 04/2003
2	Colorectal Neoplasms (Colorectal Cancer) 12/2009 - 10/2000
2	Inflammation (Inflammations) 12/2004 - 11/2000
2	Atherosclerosis 12/2004 - 04/2001
2	Necrosis 03/2002 - 07/2000
2	Lewis Lung Carcinoma 10/2001 - 01/2000
2	Hepatocellular Carcinoma (Hepatoma) 09/2001 - 01/2001
2	Colonic Neoplasms (Colon Cancer) 09/2001 - 01/2000
2	Septic Shock (Toxic Shock Syndrome) 06/2001 - 04/2001
2	Rheumatoid Arthritis 11/2000 - 10/2000
2	Pathologic Constriction (Stenosis) 07/2000 - 06/2000
1	Liver Failure 06/2017
1	Crush Injuries 01/2017
1	Peripheral Nerve Injuries 01/2017
1	fetal inflammatory response syndrome 01/2015
1	Osteoporosis 09/2014
1	Low Back Pain (Lumbago) 09/2014
1	Paralysis (Palsy) 05/2014
1	Wounds and Injuries (Trauma) 05/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 05/2014
1	Neutropenia 01/2014
1	Ovarian Neoplasms (Ovarian Cancer) 01/2014
1	Febrile Neutropenia 01/2014
1	Ovarian Epithelial Carcinoma 01/2014
1	Factor VII Deficiency (Hypoproconvertinemia) 01/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2012
1	Carcinoma (Carcinomatosis) 08/2012
1	Skin Neoplasms (Skin Cancer) 08/2012
1	Rectal Neoplasms (Rectal Cancer) 05/2012
1	Hypertension (High Blood Pressure) 03/2009
1	Malignant Hypertension 03/2009
1	Stroke (Strokes) 03/2009
1	Vascular Remodeling 03/2009
1	Genetic Predisposition to Disease (Genetic Predisposition) 03/2009
1	Fibrosis (Cirrhosis) 07/2008
1	Ureteral Obstruction 07/2008
1	Esophageal Squamous Cell Carcinoma 04/2008

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 01/2015 - 04/2001
3	Antineoplastic Agents (Antineoplastics)IBA 05/2014 - 12/2000
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2002 - 07/2000
3	Matrix Metalloproteinase InhibitorsIBA 05/2001 - 01/2000
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017 - 05/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2015 - 12/2000
2	CalciumIBA 10/2012 - 03/2001
2	Irinotecan (Camptosar)FDA LinkGeneric 12/2009 - 01/2001
2	Interleukin-10 (Interleukin 10)IBA 03/2009 - 12/2004
2	Connective Tissue Growth FactorIBA 07/2008 - 02/2008
2	Peptides (Polypeptides)IBA 07/2008 - 04/2000
2	AdrenomedullinIBA 07/2008 - 04/2000
2	AntibodiesIBA 04/2003 - 07/2000
2	nedaplatinIBA 10/2001 - 01/2001
2	N-alpha-(4-(2-phenyl-2H- tetrazole-5-yl) phenyl sulfonyl)-D-tryptophanIBA 05/2001 - 01/2000
2	Matrix Metalloproteinases (MMPs)IBA 05/2001 - 08/2000
2	EnzymesIBA 11/2000 - 01/2000
2	AcidsIBA 02/2000 - 01/2000
1	C-Reactive ProteinIBA 01/2015
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2015
1	HaptoglobinsIBA 01/2015
1	Glycoproteins (Glycoprotein)IBA 01/2015
1	Vincristine (Oncovin)FDA LinkGeneric 01/2015
1	Rituximab (Mabthera)FDA Link 01/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2015
1	Prednisone (Sone)FDA LinkGeneric 01/2015
1	YM 529IBA 09/2014
1	Diphosphonates (Bisphosphonates)IBA 09/2014
1	LigandsIBA 05/2014
1	Endoplasmic Reticulum Chaperone BiPIBA 05/2014
1	Factor VIIa (Activated Factor VII)IBA 01/2014
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2014
1	EndorphinsIBA 10/2012
1	Biomarkers (Surrogate Marker)IBA 10/2012
1	NeuropeptidesIBA 10/2012
1	ArsenicIBA 08/2012
1	Drinking WaterIBA 08/2012
1	ProdrugsIBA 12/2009
1	Fluorouracil (Carac)FDA LinkGeneric 12/2009
1	Loratadine (Alavert)FDA Link 01/2009
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2009
1	Cyclic AMP (AMP, Cyclic)IBA 07/2008
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2008

Therapy/Procedure

7	Therapeutics 12/2009 - 02/2000
4	Drug Therapy (Chemotherapy) 01/2015 - 01/2001
3	Oral Administration 11/2000 - 01/2000
2	Aftercare (After-Treatment) 01/2017 - 09/2015
2	Injections 01/2017 - 05/2014
2	Stents 07/2000 - 06/2000
1	Liver Transplantation 06/2017
1	Nerve Crush 01/2017
1	Hysterectomy 01/2014
1	Surgical Amputation (Amputations) 05/2012
1	Sternotomy 02/2009
1	Thoracotomy 12/2008